The right patient for the right therapy The 13th Annual Meeting of the Association for Cancer Immunotherapy connects the global cancer immunotherapy community in the heart of Europe.
As the largest meeting focused on cancer immunotherapy research and development in Europe, CIMT 2015 is expected to bring together 1,000 international participants for high-level scientific exchange, collaboration, and education focused on cancer immunotherapy. In addition, CIMT unites leading international experts through working groups on immune monitoring, drug development policies, and the translation of scientific knowledge into drug development.
For 2015, the CIMT program committee is preparing plenary sessions on the topics of therapeutic vaccination, cellular therapy, improving immunity, combination therapy and personalized therapy, a poster exhibit and selected poster short talk sessions.
The CIMT program committee is calling for abstract submissions in the categories Therapeutic Vaccination, New Targets & New Leads, Tumor Biology & Interaction with the Immune System, Immunomonitoring, Cellular Therapy, and Improving Immunity.
All accepted abstracts will be presented as posters. Selected abstracts will be presented as short talks. The 2015 abstract submission has been extended through Friday, March 6 (midnight, CET).
Click here to submit your abstract.
On a parallel track, CIMT will host Endeavour, a workshop on the translation and commercialization of cancer immunotherapies and diagnostics.
On the morning of day 1, the CIMT Immunoguiding Program (CIP) will lead a special pre-congress immunoguiding workshop, also at Rheingoldhalle Congress Center. Download the CIP program flyer.
On May 12, CIMT will hold a workshop on the translation and commercialization of cancer immunotherapies and diagnostics. The morning workshop will take place parallel to the sessions of the main meeting.
Scientists from the CIMT Annual Meeting community are invited to submit a research abstract for the CIMT 2015 Endeavour workshop and change their perspective from science to business.
At CIMT Endeavour, selected abstract authors will be able to present their research findings to a panel of renowned experts in the fields of cancer immunotherapy, intellectual property and commercialization. They will explore which success factors are already in place and which critical elements are missing in order to develop a commercially viable product. Go to http://www.abstractserver.de/cimt2015/absmgm/ to submit your abstract.
The workshop is open to the general public. The registration fee of 50 EUR includes lunch, snacks and drinks. A registration discount of 20 EUR will be given to participants already registered for the CIMT Annual Meeting.
CIMT Endeavour 2015 is organized in cooperation with Ci3, High Tech Coporate Services and Oslo Cancer Cluster and is supported by a grant from the German Ministry of Education and Science (BMBF).
Download the Endeavour program and see http://endeavour.cimt.eu/ for more information.
For more information, please contact email@example.com